For the year ending 2025-12-31, IRD has $50,243K in assets. $34,895K in debts. $45,091K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 45,091 | |||
| Accounts receivable | 1,995 | |||
| Contract assets and unbilled receivables (note 10) | 1,170 | |||
| Prepaids and other current assets | 1,788 | |||
| Short-term investments | 0 | |||
| Total current assets | 50,044 | |||
| Property and equipment, net | 199 | |||
| Total assets | 50,243 | |||
| Accounts payable | 3,293 | |||
| Accrued expenses and other liabilities | 4,488 | |||
| Total current liabilities | 7,781 | |||
| Warrant liabilities | 25,985 | |||
| Funding agreement, related party | 1,129 | |||
| Total liabilities | 34,895 | |||
| Common stock, par value 0.0001 125,000,000 authorized as of december 31, 2025 and 2024 69,894,507 and 31,574,657 shares issued and outstanding at december 31, 2025 and 2024, respectively | 7 | |||
| Additional paid-in capital | 203,930 | |||
| Accumulated deficit | -188,589 | |||
| Total stockholders' equity | 15,348 | |||
| Total liabilities, series a preferred stock, and stockholders' equity | 50,243 | |||
Opus Genetics, Inc. (IRD)
Opus Genetics, Inc. (IRD)